September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Analysis of Choroidal Neovascularization in myopic eyes using OCT Angiography
Author Affiliations & Notes
  • Jean-Francois Korobelnik
    Ophthalmology, CHU de Bordeaux, Bordeaux, France
  • Yona GEISMAR
    Ophthalmology, CHU de Bordeaux, Bordeaux, France
  • Marie-Noelle Delyfer
    Ophthalmology, CHU de Bordeaux, Bordeaux, France
  • Marie B Rougier
    Ophthalmology, CHU de Bordeaux, Bordeaux, France
  • Footnotes
    Commercial Relationships   Jean-Francois Korobelnik, Alcon (C), Alimera (C), Allergan (C), Bayer (C), Horus (C), Novartis (C), Roche (C), Thea (C), Zeiss (C); Yona GEISMAR, None; Marie-Noelle Delyfer, Allergan (C), Bayer (C), Novartis (C), Thea (C); Marie Rougier, Allergan (C), Bayer (C), Novartis (C), Thea (C), Zeiss (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2138. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jean-Francois Korobelnik, Yona GEISMAR, Marie-Noelle Delyfer, Marie B Rougier; Analysis of Choroidal Neovascularization in myopic eyes using OCT Angiography. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2138. doi:

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose : To analyze the benefit of optical coherence tomography angiography (OCTA) for the diagnosis of myopic choroidal neovascularization (CNV) and discuss the clinical utility of this method as compared to fluorescein angiography

Methods : Eleven eyes of 11 consecutive highly myopic patients with suspected diagnosis of CNV underwent retinal imaging with OCTA (Carl Zeiss Meditec®, Dublin, CA) between May 2015 and October 2015. Fluorescein angiography (FA, Spectralis®, Heidelberg Engineering, Germany) was performed to further validate the diagnosis of myopic CNV.

Results : In 9 eyes out of 11 patients, CNV was visualized on OCTA. 2 groups were constituted. In all eyes with CNV, the diagnosis was confirmed using OCTA. In Group 1, 9 patients with myopic CNV either naive or previously were treated with at least 1 intravitreal injection of anti-VEGF. In Group 2, 2 eyes did not show any CNV, either with FA, or with OCT A. In these two patients, final diagnosis was subretinal hemorrhage related to lacquer cracks.

Conclusions : OCT A easily shows the choroidal neovascular network of myopic CNV. Further larger studies are required to confirm our data and state whether FA is still required in this indication.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.